Cell morphology in eubacteria is determined mainly by the peptidoglycan layer that is synthesized by a battery of cytoplasmic and membrane-bound enzymes, among which are the DDpeptidases (26, 42, 61) . These peptidases, commonly designated penicillin-binding proteins (PBPs), are serine-active enzymes that belong to a large family of penicillin-recognizing proteins whose active sites contain three conserved motifs. Generally, the PBPs lose their DD-peptidase activity by forming a long-lived covalent bond with penicillins (26) .
The PBPs are separated into two large groups on the basis of their sizes. The low-molecular-mass proteins are essentially monomodular DD-peptidases that have been shown to play a morphogenetic role in Escherichia coli as well as in Streptococcus pneumoniae cells (11, 12, 41, 43, 66) . In contrast, the highmolecular-mass PBPs are essential bimodular enzymes that bind penicillins on their C-terminal module. They are further subdivided into two classes. Class A PBPs have an N-terminal module acting as a glycosyltransferase and are characterized by the presence of five typical conserved amino acid motifs. Class B PBPs possess three conserved amino acid motifs in their N-terminal modules that have no detectable enzymatic activity but seem, however, to be essential for cell morphogenesis (26) .
Different observations suggest that rod-shaped bacteria possess two morphogenetic systems, one responsible for cell elongation and the other responsible for cytokinesis (50, 52) . For example, separate inactivation of E. coli class B PBP2 and PBP3 either by ␤-lactam antibiotics or by mutagenesis shows that the first is specifically required for cell elongation and that the second is required for cell division (4, 59) . In addition, two protein complexes containing different PBPs could be isolated from Haemophilus influenzae and Bacillus subtilis cells (1, 58) .
Consistent with their function, PBP3 of E. coli (38, 63, 65) or PBP2b and PBP1 of Bacillus subtilis (54) localize in the area of developing septa and of completed poles. These PBPs are part of a multiprotein-synthesizing machinery, designated the divisome (6, 21, 42, 54) , whose assembly has been studied by different approaches (16, 31, 38, 45, 63) .
The composition of the multiprotein complex needed for cell elongation is not yet well documented, but it is thought to be structurally analogous to the divisome (30) . In addition to pbpA, encoding PBP2, other different genes such as rodA (59, 60) and mreBCD (33, 54, 60) are required for elongation in E. coli.
Morphogenesis of cocci was thought to be relatively simple, with most of the cell wall synthesis taking place at the site of septum formation (25, 28) . However, on the basis of the inhibition of cell division by antibiotics or by thermosensitive mutations, it was proposed that they be separated into two groups: those that possess a site for septum formation only and those that in addition have a site for lateral wall elongation that would be less effective than that in rod-shaped cells (35, 52) . Staphylococcus aureus is probably a member of the first group, as cell wall synthesis appears to occur only at the division site (48) .
The low susceptibility of enterococci to ␤-lactams is due to the activity of a low-affinity class B PBP, designated PBP5 (23, 64) . In the presence of antibiotic concentrations that inhibit all the PBPs except PBP5, enterococci continue to multiply (22) . Under these conditions, even in highly resistant strains, PBP5 maintains sufficient transpeptidase activity to synthesize a normal peptidoglycan in Enterococcus faecium and Enterococcus hirae (7, 55, 67) . When grown in the presence of sub-MIC concentrations, the penicillin-resistant Enterococcus faecalis strain 56R has a slightly less cross-linked peptidoglycan with fewer oligomers but more dimers than the wild type (56) . Note that when PBP5 is the only active DD-transpeptidase, these cells also need the help of an active glycosyltransferase to synthesize peptidoglycan, as class B PBPs were shown to be unable to polymerize glycan strands (26, 49) .
Different morphological observations of ␤-lactam-treated enterococcal cells indicate that they should have two cell wall-synthesizing machineries (52) . Treatment of E. hirae ATCC 9790 with ampicillin or cephalotin concentrations that have little effect on the increase in cell growth but that result in a relatively strong inhibition of cell division lead to a doubling of average volumes and lengths of the cells during a 60-min period (29) . Under these conditions, on the basis of 50% inhibitory concentrations, all the PBPs except PBP5 should be saturated (9) .
Exponential-phase cells of E. hirae ATCC 9790 treated with low concentrations of cefotaxime (Յ0.25 ϫ MIC) form bloated rods in which septa are initiated but not formed as a result of the specific inhibition of class B PBP2 and PBP3 (10) . It was also shown that when thermosensitive PBP3 E. hirae mutants constitutively overproduce PBP5, they grow normally at the nonpermissive temperature (8) . This again indicates that PBP5 can compensate for the lack of PBP3 that is determined by a gene located in the dcw cluster devoted to cell division (17) . Presumably, like in other bacteria (42, 62) , when PBP3 is specifically inhibited, the divisome is inactivated, and the cells continue to build their peptidoglycan with their peripheral wall-synthesizing complex. One may suppose that to be able to fulfill its suppletive activity in E. hirae, PBP5 is integrated into the divisome with PBP3 or into a multiprotein biosynthetic machinery that has similar functions.
In this study, we modified E. hirae cells to place PBP3 synthesis under the control of the nisAp promoter that is strongly repressed in the "nisin-controlled expression" (NICE) system that was successfully used to analyze the expression of different genes in various gram-positive bacteria (15, 46) . Our results indicate that for several hours, noninduced recombinant cells do not produce PBP3, stop dividing, and elongate. However, if PBP5 is synthesized, these cells divide normally in spite of the absence of PBP3. In parallel, examination of the N-terminaldomain sequence of PBP5 with a predictive method that was used to establish the functionality of different regions of E. coli PBP3 and FtsW led to the identification of potential proteinprotein interacting segments (24, 38, 47) . Some residues in these segments were modified by site-directed mutagenesis. One residue appeared to be crucial to maintain the stability of PBP5, and another seemed to be more specifically required for its suppletive activity in noninduced cells.
MATERIALS AND METHODS
Bacterial strains, media, growth conditions, and MIC determinations. The E. coli and E. hirae strains used in this work are listed in Table 1 . E. coli strains were grown in Luria broth (LB) at 37°C. E. hirae strains were grown in either M17 medium to prepare electrocompetent cells (51) or brain heart infusion (BHI) broth at 37°C or at 28°and 42°C when homologous recombinants were isolated. Growth curves were established by measuring the absorbance at 550 nm (A 550 ) or by determining cell numbers on plates at regular intervals. The media were supplemented with ampicillin (100 g/ml) (Bristol-Myers Squibb, Brussels, Belgium), kanamycin (100 g/ml) (Calbiochem, Bierges, Belgium), chloramphenicol (10 g/ml), erythromycin (5 or 10 g/ml) (both from Fluka, Bornem, Belgium), and benzylpenicillin (PenG) (0.1 g/ml) (Aventis, Lyon, France) as indicated.
Other selective additives such as 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) (40 g/ml), isopropyl-␤-D-thiogalactopyranoside (IPTG) (7 g/ml) (both from Immunosource, Zoersel-Halle, Belgium), and 5-bromo-4-chloro-3-indolyl-glucuronide (X-Gluc) (0.5 mM) (Research Organics Inc., Cleveland, Ohio) were used or applied to the media as required. MICs were determined in 1 ml of BHI broth in 24-well culture plates, in at least three independent determinations, essentially as previously described (51).
Plasmid constructions. Common E. coli plasmids (Table 1) were used for cloning purposes. Gene disruption or replacement experiments were carried out by using the pER924 shuttle vector as previously described (51) .
(i) pDML1615. A 2.2-kb pbp3 fragment was amplified by PCR by using the DNA of ATCC 9790 as a template and primers SELpbp3BamHI and SELpbp3SacI (Table 2) . These oligonucleotides were designed to place a BamHI site just upstream of the pbp3 ATG codon and a SacI site just downstream of the stop codon, respectively. The pbp3 fragment was cloned into pUC18, which was used as an intermediate, since for unknown reasons, direct cloning into pNZ8020 was unsuccessful. The pbp3 gene was then transferred into pNZ8020 under the dependence of the nisAp promoter (nisAp-pbp3 fusion) to generate pDML1615.
(ii) pDML1621. A 3.6-kb chromosomal DNA fragment of E. hirae SL1, which contained the entire pbp3 gene as well as the upstream mraW and ftsL and downstream mraY genes, was amplified by PCR by using primers MFPMupBamHI and MFPMlowEcoRI (Table 2 ) and cloned into BamHI-and EcoRI-digested pUC18 to obtain pDML1616 (see the supplemental material).
By digestion with BamHI and KpnI (the KpnI site is present in the last quarter of pbp3), the pDML1616 insert was reduced to 2.6 kb and cloned into pUC18 to generate pDML1617, where it was mutagenized to introduce an NcoI restriction site at the level of the starting ATG codon of pbp3 (NcoIup and NcoIlow primers) ( Table 2 ) by site-directed mutagenesis. That new plasmid, containing both the mraW and ftsL genes as well as a large part of pbp3 (designated below as pbp3a), was named pDML1618.
In parallel, the 0.8-kb kanamycin resistance cassette (aph3Ј or Km r gene) present in pDG792 was amplified by PCR by using primers KANup-NcoI and KANlowKpnI (Table 2 ) (the NcoI site overlapped the Km r gene starting ATG codon), cloned into the pGEM-T Easy vector, digested by the NcoI and KpnI enzymes, and finally substituted into pDML1618 for the 1.6-kb pbp3a fragment. The resulting plasmid, pDML1619, was then digested by the BamHI and KpnI restriction enzymes to isolate the 1.8-kb mraW-ftsL-Km r fragment that was introduced into pDML1616 as a substitute for the 2.6-kb mraW-ftsL-pbp3a fragment. The resulting plasmid, pDML1620, thus contained the mraW-ftsL-Km r -pbp3b-mraY genes (pbp3b corresponds to the terminal end of pbp3) that were finally excised by BamHI and EcoRI digestion and cloned into the thermosensitive shuttle vector pER924 to obtain pDML1621 (see the supplemental material).
(iii) pDML1626 and pDML1627 to pDML1633. The 2.6-kb pbp5 insert of pDML546 was cloned into pBR322 at the SalI and EcoRI sites to yield pDML1626. When fused at the EcoRI site of pIL253, it produced the E. coli/E. hirae shuttle vector pDML1627. Plasmids pDML1628 to pDML1633 were the result of similar fusions with the different pDML1626 mutants.
(iv) pDML2230 and pDML2231. Two plasmids carrying the pbp5 gene of E. faecium (pbp5 Efm ) with its promoter and terminator sequences were constructed with the 2.2-kb PCR fragment amplified from pDML517 with primers ON1 and ON2*, which were designed to introduce the EcoRI and BamHI sites at each end, respectively. That 2.2-kb PCR fragment was cloned into pBR322 to yield pDML1699, which was then fused to pIL253 to generate pDML2330. It was also inserted into vector pUC18del that was obtained after the removal of AatII-XbaI from pUC18. Plasmid pDML1698, thereby obtained, was used to mutagenize the Ser422 residue and then construct the pDML2231 shuttle vector.
Construction of the E. hirae pbp5::nisRK SL1 strain. A 2.4-kb blunt-ended HpaII-PstI DNA fragment that contained the complete nisRK operon was isolated from plasmid pNZ9500 and inserted into the blunt-ended SstI site (position 1144 from the pbp5 ATG codon) inside the 1.6-kb pbp5 fragment of pDML1600 to generate pDML539. The 4-kb EcoRI-BamHI pbp5::nisRK fragment isolated from pDML539 was cloned into the thermosensitive pER924 shuttle vector to construct the integrative plasmid pDML1614, which was used to electroporate E. hirae ATCC 9790 cells and to isolate, as previously described (51), pbp5-negative double recombinants appearing on plates as penicillin-sensitive pbp5-negative colonies.
The susceptibility of these pbp5-negative clones, verified by measuring the penicillin MIC, as expected, was 40 times higher (MIC ϭ 0.015 g/ml) than that of the parental strain (0.6 g/ml) (51). Integration of the nisRK gene cluster into pbp5 was also verified by PCR by using both pbp5 4546 and pbp5 B4 primers (Table 2 ), which hybridized upstream and downstream, respectively, of the insertion point in pbp5. The PCR fragments obtained from the recombinants were 2.4 kb longer (4.7 kb) than those obtained from ATCC 9790 (2.3 kb), indicating that the nisRK fragment had been inserted (results not shown). Membranes of a randomly picked pbp5::nisRK recombinant, designated SL1, were prepared, labeled with [ 14 C]PenG, and compared with those of ATCC 9790 and the penicillin-resistant strain R40, which overproduces PBP5. As expected, SL1 did not synthesize PBP5 (Fig. 1A) .
General DNA methods. Standard DNA methodologies were used (2) . DNA fragments, PCR products, plasmids, and the genomic DNA of Enterococcus cells (collected at the end of the exponential phase) were purified as previously reported (36, 51) . E. hirae plasmids were isolated from protoplasts prepared from cells at the end of the exponential phase that were lysed for 30 min at 37°C with lysozyme (3 mg/ml) in a solution containing 10 mM Tris, 1 mM EDTA, and 27% (wt/vol) sucrose (pH 8) and collected by low-speed centrifugation (3,000 rpm for 3 min). Nucleotide sequencing was performed as previously described (51), with Cy5 primers identical to some of those shown in Table 2 . Restriction endonucleases from Promega (Leiden, The Netherlands), Life Technologies (Merelbeke, Table 2 ). The Taq, Pwo, Vent, and Biotools DNA polymerases from Amersham Pharmacia Biotech, Eurogentec, New England Biolabs (Westburg, Leusden, The Netherlands), and Labsystem (Brussels, Belgium), respectively, were used according to the manufacturers' recommendations. Amplifications were usually carried out as previously described (51) .
Directed mutagenesis. The site-directed mutagenesis of pbp5 was performed with the QuickChange site-directed mutagenesis kit (Stratagene Europe, Amsterdam, The Netherlands) on a 270-bp fragment encoding the S 125 -A 215 peptide of PBP5 that was excised from pDML541 by a double HindIII and PstI digestion and cloned into pUC18 to generate pDML1623. Primer pairs O5M1a/O5M1b, O5M2a/O5M2b, O5M3a/O5M3b, O5M5a/O5M5b, and O5M6a/O5M6b (Table  2) were used to produce the K 172 N/R 173 N (M1 mutant), K 199 Q/K 203 Q (M2 mutant), K 203 Q (M3 mutant), R 173 N (M5 mutant), and K 199 Q (M6 mutant) substitutions, respectively. The resulting plasmids were named pDML1623M1, pDML1623M2, pDML1623M3, pDML1623M5, and pDML1623M6, respectively. The HindIII-PstI fragments carrying the different mutations were then exchanged with the corresponding fragment of pDML1626 to obtain pDML1626M1, pDML1626M2, pDML1626M3, pDML1626M5, and pDML1626M6, respectively.
To introduce the five K-to-S substitutions in the N-terminal end of PBP5, a 390-bp NcoI-SpeI fragment was isolated from pDML545 and cloned into pSL1190 to generate pDML1697. The construct was then mutagenized in three successive steps with three pairs of primers, O1K75K76/O1K75K76*, O2K108K109/O2K108K109*, and O3K146/O3K146* ( Table 2 ). The final mutated fragment was then exchanged with the corresponding wild-type fragment of pDML541 by a double ScaI-SpeI digestion. The ScaI site is present 60 bp downstream of the NcoI site. Finally, the mutated pbp5 gene was introduced into pDML1626 by exchange of the EcoRI-SalI fragment to generate pDML1626M4.
The S422A substitution of PBP5 Efm was made in pDML1698 by site-directed mutagenesis with the ON6 and ON7* primers. The AccI fragment isolated from the S 422 A pbp5 Efm [ pbp5 Efm (S422A)] gene was then exchanged with that of pDML1699 to generate pDML1699S 422 A, which was fused to pIL253 at the EcoRI site to yield pDML2331.
Transformation of E. hirae cells and isolation of recombinants. E. coli competent cells and E. hirae electrocompetent cells were transformed as previously described (2, 51). Gene disruptions or deletions in E. hirae cells were achieved by (67) . Except when stated otherwise, 200-g protein samples were used. Modification of the fluorography procedure, detection of labeled PBPs, and Western blot analysis with anti-PBP5 rabbit polyclonal antibodies were previously described (51) . The truncated soluble PBP5 Efm used as a control in some of these procedures was obtained as previously described (53) .
␤-Glucuronidase activity. Nisin was obtained from Sigma as a 2.5% solution in sodium chloride containing denatured milk proteins. Stock solutions of nisin were made by suspending 10 mg of the nisin mixture per ml of 0.05% acetic acid and then diluting the preparation (10-fold) with dimethyl sulfoxide. These stock solutions were stored at Ϫ20°C. Further dilutions were made with water and were used immediately.
For quantitative ␤-glucuronidase assay, E. hirae cells were grown up to an A 550 of 0.5, induced with different nisin concentrations, grown for another 90 min, and harvested. After being resuspended in 50 mM NaHPO 4 buffer (pH 7) to a final A 600 of 2.0, these cells were permeabilized and used immediately for the glucuronidase assay in the presence of 100 mM para-nitrophenyl-␤-D-glucuronic acid (Clontech Laboratories, Inc., Palo Alto, Calif.) as previously described (34) .
Prediction of interaction sites. In the method used here, a 7-or 11-amino-acid segment is moved along the primary structure of a protein one residue at a time. For the central residue of each segment, a mean hydrophobicity, ϽHϾ, value and a mean hydrophobic moment, ϽϾ, value were calculated. Both values characterizing each residue were plotted (18, 19, 24) . It has been determined that different putative sites possess one or several residues for which ϽHϾ values are smaller than Ϫ0.5 and ϽϾ values are greater than 0.5. Replacements of one residue that in principle do not modify the secondary and tertiary structures may affect the predicted amphiphilicity. Those that have the strongest influence on that property could greatly change the putative interacting capacity of a site.
RESULTS
Testing of the NICE system and the trans expression of pbp5 and pbp3 in E. hirae SL1. To be fully functional, the NICE system requires the presence and activity of the nisRK genes that signal the presence of nisin (the inducer) and activate genes placed under the control of the nisA promoter (nisAp). The two nisRK genes were thus first inserted into the pbp5 gene that was shown to be dispensable in E. hirae ATCC 9790 (51) . The thereby constructed PBP5-deficient clone, SL1, was also needed to assess the activity of PBP5 variants.
As expected, in the presence of nisin, SL1/pNZ8008 transformants appeared as blue colonies on plates containing X-Gluc but remained uncolored if noninduced. Induction of the glucuronidase activity by the nisAp-gusA gene was also followed by measuring the rate of hydrolysis of the p-nitrophenyl-␤-D-glucuronide substrate in permeabilized cells. The activity was detectable at very low concentrations of nisin (10 ng/ml) and presented, as previously shown (34), a good linear dose-response relationship up to concentrations just below the MIC (nisin MIC ϭ 5 g/ml). The activity of noninduced SL1/pNZ8008 cells remained under the limits of detection. The NICE system was thus functional in E. hirae. It is important that in spite of the presence of nisin (0.25 g/ml), the growth rates of either ATCC 9790 and SL1 or SL1/ pNZ8008 (ϳ29-min and ϳ32-min generation times, respectively) were not modified.
Expression of pbp5 Eh . The 11-kb pDML1627 shuttle vector carrying wild-type E. hirae pbp5 ( pbp5 Eh ) was used to test the trans expression of pbp5 Eh . As shown by SDS-PAGE and fluorography, radioactively labeled membranes of SL1/ pDML1627 clones designated below as SL1/pbp5 Eh , grown in the presence of erythromycin, synthesized relatively large amounts of active PBP5 Eh (Fig. 1B, lane 2) . As expected, the resistance of SL1/pbp5 Eh cells to PenG was much increased (MIC ϭ 20 g/ml) compared to that of the parental SL1 strain. The PBP5 Eh produced in SL1 was thus functional.
Expression of the nisAp-pbp3 fusion. To assess the ability of native and mutant forms of PBP5 Eh to substitute for PBP3, we needed a strain whose PBP3 synthesis could be controlled. We chose to inactivate the chromosomal gene in the presence of the inducible nisAp-pbp3 gene fusion carried on the pDML1615 plasmid. However, the expression of that fusion had to first be tested.
Induced PBP3 synthesis in SL1/pDML1615 transformants, designated below as SL1/pbp3i, progressively increased with increasing nisin concentrations of up to 2 g/ml (Fig. 2) . Synthesis of PBP3 in noninduced SL1/pbp3i remained weak and was most probably due to the chromosomal gene that is still present. It is important that neither the growth nor the morphology appeared to be changed in E. hirae SL1/pbp3i cells producing large amounts of PBP3.
Isolation of SL2, a pbp3-conditional derivative of SL1. Inactivation of the chromosomal pbp3 gene was performed in SL1/pbp3i cells transformed with the integrative pDML1621 vector. Nisin (0.5 g/ml) and chloramphenicol (10 g/ml) were added to the medium at all steps to produce enough PBP3 in the absence of the chromosomal pbp3 and to maintain pDML1615, respectively. However, no kanamycin-resistant colonies were found. Double pbp3-deficient recombinants could nevertheless be differentiated, as in the absence of nisin, they formed colonies much later (minimum of 2 days) than parental SL1/pbp3i cells. One randomly picked pbp3-deficient SL1/pbp3i recombinant was named SL2.
PCRs were used to verify the integration of the 0.8-kb kanamycin cassette. It was amplified by using primers KANup-NcoI and KANlow-KpnI (Table 2 ) from SL2 cells but not from SL1 cells. In addition, PCR fragments obtained from pDML1616 and SL1 (two pbp3 controls) were 0.8 kb longer than those (2.8 kb) obtained from pDML1621 and SL2 when primers MFPMupBamHI and MFPMlowEcoRI (Table 2) , which hybridized at both ends of the mraW-ftsL-pbp3-mraY locus, were used (data not shown). That difference was in good accordance with the replacement of the PBP3a fragment by the Km r cassette. One could explain the lack of kanamycin resistance of the recombinants by either a lack of activity of the Km r gene or, more probably, an insufficient expression of the Km r gene due to a pbp3 promoter that was too weak. As the recombinants grew normally, Induced SL2 cells (0.25 g of nisin/ml) grown overnight in BHI broth supplemented with chloramphenicol were collected by centrifugation, resuspended in nisin-free medium, and used as inoculum (1%). As can be seen in Fig. 3 , after a short lag period (Ͻ1 h), induced SL2 cells could multiply almost as fast as SL1 cells (ϳ37-min and ϳ32-min generation times, respectively). Noninduced SL2 cells, unable to synthesize both PBP5 and PBP3, did not divide for about 8 h before they resumed their growth at a slower rate (ϳ70-min generation time). In Fig. 3 , all the samples were plated in the presence of nisin, but when they were plated onto nisin-free medium, during about the first 7 h of the lag, the cells of the inoculum (ϳ5 ϫ 10 6 cells/ml) needed at least 5 days to form colonies. The number of cells capable to produce colonies after only 1 day then progressively increased (results not shown). It is important that when subcultured in nisin-free liquid medium, cells collected after regrowth in the absence of nisin grew without going through a long lag period.
Complementation of the PBP3 deficiency in SL2 by PBP5. (i) Complementation by PBP5 of E. hirae. SL2 cells were transformed with pDML1627 bearing the pbp5 Eh gene to assess the complementation activity of PBP5 when PBP3 was not produced in noninduced SL2 cells. Chloramphenicol and erythromycin were always present in the medium, and noninduced SL2/pDML1627 cells designated below as SL2/pbp5 Eh (culture grown overnight) were used as inoculum (1%). As can be seen in Fig. 3 , noninduced and induced SL2/pbp5 Eh cells had slightly longer lag periods than induced SL2 cells. However, induced SL2/pbp5 Eh cells multiplied more rapidly than noninduced SL2/pbp5 Eh and induced SL2 cells (ϳ27-min and ϳ38-min generation times, respectively). Thus, by producing PBP5, induced (producing PBP3) or noninduced (not producing PBP3) SL2/pbp5 Eh cells behaved much more like SL1 and ATCC 9790 cells than like noninduced SL2 (PBP3-deficient) cells.
PBP profiles of radioactively labeled membranes of noninduced SL2 and noninduced and induced SL2/pbp5 Eh cells were compared with those of membranes of the wild-type strain, the PenG-resistant R40 strain, and the SL1 and induced SL2 strains. It is worth noticing that the noninduced SL2 cells, collected during the growth phase that followed the 8-h lag period, produced as much PBP3 as the ATCC 9790, R40, SL1, and SL2/pbp5 Eh cells used as controls (Fig. 4A) . Obviously, in those noninduced SL2 cells, expression of the pbp3 gene was, for unknown reasons, made possible again.
It is important that noninduced SL2/pbp5 Eh cells produced PBP5 but not PBP3 (Fig. 4A and B) . When nisin was present, the same cells produced PBP3 at the same time as PBP5. In both cases, the amount of PBP5 was apparently similar. One can conclude that, in contrast to the noninduced SL2 cells collected after the 8-h latent period, in the SL2/pbp5 Eh cells, the nisAp promoter was not activated. One may thus conclude that when PBP5 is produced in these cells, it is able to replace PBP3.
(ii) Complementation by PBP5 of E. faecium. As the PBP5 of E. faecium (PBP5 Efm ) was shown to be closely related (80% identity) to that of E. hirae (PBP5 Eh ) (67), both proteins were compared for their complementation activity in noninduced SL2 cells. An S 422 A PBP5 Efm [PBP5 Efm (S422A)] mutant, unable to bind [ 14 C]PenG and used as a control in binding experiments, was included in the assay to confirm that the DDpeptidase activity was essential for complementation.
Two shuttle plasmids, pDML2330 ( pbp5 Efm ) and pDML2331 [pbp5 Efm (S422A)], analogous to those described above to produce PBP5, were used to complement SL2 cells. Production of the PBP5 Efm variants was verified by Western blot analysis (data not shown). Nisin-induced SL2/pbp5 Efm and SL2/pbp5 Efm (S422A) cells grew at almost the same rate (ϳ40-min generation time) but slower than induced SL2/pbp5 Eh cells (ϳ27-min generation time). PBP5 Efm could complement the PBP3 deficiency but apparently not to the same extent as PBP5 Eh . Noninduced SL2/pbp5 Efm cells indeed multiplied at a slower rate (ϳ60-min generation time) than SL2/pbp5 Eh cells (ϳ38-min generation time). The PBP5 Efm mutant synthesized in those noninduced cells did not help them to recover their division processes. Their growth curves were not different from those of noninduced SL2 cells with an ϳ8-h latent phase preceding slow growth.
In conclusion, PBP5 Efm is able to rescue cells that do not synthesize PBP3 but apparently with a lower efficiency than its ortholog. It is also clear that for that compensatory activity, PBP5 Efm needs to have a functional DD-peptidase module.
Identification of putative protein-protein interaction sites in the N-terminal module. Because of its very high identity with PBP5 Efm (67), PBP5 Eh should have a three-dimensional structure very similar to that established for PBP5 Ef (Fig. 5) (53) . Calculation of ϽHϾ and ϽϾ values based on the primary structure of PBP5 Eh led to the identification of six segments that were positioned in the N-terminal module made of a long and narrow ␤-sheet formed by three strands and bearing two small globular domains ( (Fig. 5) . The effects of these five substitutions on the amphiphilicity of sites A, B, and C were not estimated by the predictive method.
SL1 cells were transformed separately by these different shuttle vectors and grown in BHI in the presence of erythromycin. Isolated membranes of the different SL1 transformants were labeled with [ (Fig. 1B) . These mutations had apparently no structural impact on PBP5 Eh , as the binding activities appeared to be normal. In contrast, SL1/pDML1628 and SL1/pDML1632 transformants bearing the pbp5(K172N/R173N) and pbp5 (R173N) mutations, respectively, did not synthesize any PBP5, as it could not be detected by either radioactive labeling or Western blot analysis with anti-PBP5 antibodies. As both plasmids were reisolated from these transformants and were shown to have the expected sizes and restriction sites, one can conclude that the lack of PBP5 Eh was not due to visible plasmid modifications. However, the sequences of these pbp5 Eh mutants were not verified.
Complementation of PBP3-deficient SL2 by the mutated PBP5s. The capacity of the different PBP5 Eh variants to complement the PBP3 deficiency in noninduced SL2 cells was analyzed in several separate experiments by growing the different transformants in liquid medium as described above. The pDML1628 [pbp5(K172N/R173N)] and pDML1632 [pbp5(R173N)] plasmids were not included in these assays. The growth curves were established by monitoring the absorbance or the cell counts and remained similar for each clone in the different experiments. Those shown in Fig. 3 were based on cells counts made on plates containing nisin (0.25 g/ml).
The four pbp5(K199Q/K203Q), pbp5(K203Q), pbp5(5K-S), and pbp5(K199Q) mutants multiplied at rates similar to that of noninduced SL2 cells (ϳ70 min), but they differed greatly in their lag periods. In addition, some of them reached the stationary phase much earlier than the controls. The pbp5 (K199Q) and pbp5(5K-S) cells needed about 3 h to reach the exponential phase. However, the pbp5(5K-S) cells stopped growing earlier than pbp5(K199Q) cells. The pbp5(K203Q) mutant and the pbp5(K199Q/K203Q) double mutant had to wait more than 5 h and about 7 h respectively, before they could grow regularly. In addition, pbp5(K199Q/K203Q) cells reached the stationary phase earlier than the pbp5(K203Q) cells.
On the basis of these experiments, one has to conclude that these mutations reduced, sometimes to a large extent, the complementation activity of PBP5 Eh .
DISCUSSION
The natural low susceptibility of enterococci to ␤-lactams is attributed to the protective effect of the low-affinity PBP5 that takes over most functions of the other PBPs when they are not produced or inhibited by penicillin (22, 23, 64) . This means that when the essential cell division of PBP3 is inhibited by sub-MIC concentrations of PenG and PBP5 is present, the cells continue to divide (22, 23) . E. coli and B. subtilis orthologs of E. hirae PBP3 (10, 17) interact with other membrane proteins to form the divisome, a multiprotein synthetic machinery (21, 37, 42, 62) , through specific protein-protein interactions that were recently analyzed in E. coli (6, 16, 31, 38, 39, 45, 47, 65) . For an efficient suppletive activity, the enterococcal PBP5 is probably integrated into the divisome or in a multiprotein complex with similar functions, and it should interact with one or several other proteins there.
The substitution activity of PBP5 was first specifically examined with PBP3-conditional E. hirae mutants that were unable to multiply at the nonpermissive temperature unless PBP5 was produced in large quantities (8) . Unfortunately, those mutants were generally obtained by chemical mutagenesis and were unstable (P. Canepari, personal communication).
Determination of the principal structural elements needed for the suppletive activity of PBP5 should be done in a known and stable genetic background. A relatively long genetic engineering process was thus undertaken to first insert the nisRK genes by homologous recombination into the dispensable pbp5 Eh gene (SL1 strain) (23, 51) and then inactivate the essential pbp3 gene of E. hirae SL1 in the presence of plasmidic copies of pbp3 placed under the control of the nisA promoter (nisAp-pbp3 gene fusion).
Examination of the SL2 strain thereby obtained revealed that under inducing conditions, it did not behave not differently than the ATCC 9790 and pbp5::nisRK SL1 strains used as controls. As expected, noninduced SL2 cells did not multiply, but after about 8 h, they regained the capacity to multiply at a slower rate than induced cells. That long lag period appeared to be the time they needed to bypass, by a unknown mechanism, the control imposed by the lack of inducer. Although the amount of PBP3 produced after that lag was comparable to that found in control cells, it was insufficient to restore a normal growth rate. The presence of mutants able to produce PBP3 among the SL2 cells of the inoculum is very unlikely. From the beginning and during most of the lag period, all the cells needed at least 5 days to form colonies. This indicated that each cell of the inoculum could survive on the plates and, after a certain time, was capable of multiplying in the absence of the inducer.
The SL2 strain was nonetheless a good tool to assess the complementation activity of PBP5 Eh . When PBP5 Eh was synthesized, the noninduced SL2 cells grew normally in spite of the absence of PBP3. They resumed their growth as fast as the control ATCC 9790, SL1, and induced SL2 cells. If they produced native PBP5 Efm , noninduced SL2 cells grew almost as if they were complemented with its PBP5 Eh ortholog. But if they synthesized the PBP5 Efm (S422A) variant, lacking its DD-transpeptidase activity, noninduced SL2 cells were not complemented. This confirmed that, as indicated by previous results (8, 22, 23, 51, 55, 64, 67) , to complement PBP-deficient cells, PBP5 Eh must possess a functional DD-transpeptidase module.
Predictive methods used here led to the identification of six amphiphilic peptide segments that could act as protein-protein interaction sites in the structure of PBP5 of E. hirae. Like the other low-affinity PBPs forming subgroup B1 PBPs, PBP5 Eh has a 110-amino-acid polypeptide insert that appears as a globular domain at the end of the N-terminal module of PBP5 Efm (Fig. 5) (26, 53) Sites D and E, which presented the strongest interaction potential, were mutagenized to introduce single or double substitutions that were proposed to reduce or suppress proteinprotein interactions. Two double mutants, K 172 N/R 173 N (M1 mutant) and K 199 Q/K 203 Q (M2 mutant), and three single mutants, K 203 Q (M3 mutant), R 173 N (M5 mutant), and K 199 Q (M6 mutant), were prepared. A sixth mutant (M4 mutant) was added to this list, as it possessed five lysine-to-serine replacements in the three sites identified in the globular domain at the N-terminal end of PBP5. K 75 S and K 76 S mutations were introduced into site A, K 108 S and K 109 S substitutions were made in site B, and K 146 S replacement concerned the end of site C.
The N-terminal globular domain. The Lys-to-Ser substitutions made in sites A, B, and C [ pbp5(5K-S)] did not seem to interfere much with the folding of the mutated PBP5 Eh that was overproduced in SL1 cells, as the binding of [
14 C]PenG appeared to be similar to that of PBP5 Eh . However, these substitutions modified the complementation activity of the protein, because SL2/pbp5(5K-S) cells presented a longer lag phase and a reduced growth rate and reached the stationary phase at a much lower cell density than SL2/pbp5 Eh cells producing PBP5 Eh . These results tended to indicate that the globular domain at the extremity of the N-terminal module is implicated in the suppletive action of PBP5 Eh .
Site D. The single R 173 N and double K 172 N/R 173 N replacements made in site D in motif I had a very drastic impact, as the PBP5 Eh variants were not found in E. coli and E. hirae cells grown at 37°C. One may suspect that the K172 and R173 residues are essential for the stability of the protein. The E 76 N mutation made in conserved motif I of E. coli PBP3 (variant 10) had a milder effect in reducing the thermostability of the protein, although in this case, the hydrophobic moment plot of the I 74 -L 82 segment was not modified (38) . The information gained with these mutations are in good agreement with structural observations suggesting that conserved motif I in class B PBPs has a critical stabilization role in the connection between the N-terminal and C-terminal modules (53) . However, as both mutants, prepared separately, were not totally resequenced, one cannot totally exclude the presence of mutations that would interfere with their transcription or transduction.
The central globular domain. Our results demonstrated that site E, predicted to be an important interaction site in the central globular domain, was indeed essential for the compensatory activity of PBP5 Eh . Contrary to PBP5 Eh , the PBP5(K199Q/K203Q) variant was unable to complement PBP3-deficient SL2 cells. Lysine 203 seemed to be much more important. Its replacement by a glutamine reduced the compensatory activity to a large extent. SL2/pbp5(K203Q) cells were delayed in their growth but not as much as SL2/ pbp5(K199Q/K203Q) and noninduced SL2 cells. Lysine 199 appeared to be of less importance. Its replacement (K199Q) had a lower impact on the complementation activity than the K203Q substitution. Thus, both residues seem to be required for a normal activity of PBP5 Eh , and when the two are replaced, PBP5 Eh loses its suppletive activity.
In conclusion, this work definitively demonstrates that the low-affinity PBP5 Eh alone takes over the function of PBP3 in cell division when E. hirae cells are submitted to ␤-lactam treatment. To carry out that activity, PBP5 Eh , and probably PBP5 Efm , needs the two small globular domains that are connected to the ␤-sheet of its N-terminal module and must have a functional C-terminal DD-transpeptidase module.
